Survival inequalities in head and neck cancers: A hospital-based cohort study

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
MENEZES, Fabricio dos Santos
PERES, Stela Verzinhasse
ANTUNES, Jose Leopoldo Ferreira
LATORRE, Maria do Rosario Dias de Oliveira
TOPORCOV, Tatiana Natasha
Citação
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, v.45, n.9, p.2377-2393, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BackgroundWe investigated whether the socioeconomic status (SES) influenced survival rates in oropharynx cancers (OPC), oral cavity cancers (OCC), and larynx cancers (LC) in Brazilian patients. MethodsThis hospital-based cohort study assessed the age-standardized 5-year relative survival (RS) using the Pohar Perme estimator. ResultsOverall, we identified 37 191 cases, and 5-year RS were 24.4%, 34.1%, and 44.9% in OPC, OCC, and LC, respectively. In multiple Cox regression, the highest risk of death occurred in the most vulnerable social strata for all subsites-that is, illiterates or patients relying on publicly funded healthcare services. Disparities increased over time by 34.9% in OPC due to the rising of survival rates in the highest SES, whereas they reduced by 10.2% and 29.6% in OCC and LC. ConclusionsThe potential inequities were more significant for OPC than for OCC and LC. It is urgent to tackle social disparities to improve prognoses in highly unequal countries.
Palavras-chave
head and neck cancer, healthcare disparities, mortality, oropharnyx cancer, social inequalities, survival
Referências
  1. Adrien J, 2014, ORAL ONCOL, V50, P90, DOI 10.1016/j.oraloncology.2013.10.016
  2. Agarwal P, 2020, LARYNGOSCOPE, V130, P2160, DOI 10.1002/lary.28321
  3. Anantharaman D, 2017, INT J CANCER, V140, P1968, DOI 10.1002/ijc.30608
  4. Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217
  5. [Anonymous], BRASIL LEI NO 12732
  6. Assis MMA, 2012, CIENC SAUDE COLETIVA, V17, P2865, DOI 10.1590/S1413-81232012001100002
  7. Auluck A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2579-4
  8. Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329
  9. Belot A, 2018, CLIN EPIDEMIOL, V10, P561, DOI 10.2147/CLEP.S150848
  10. Berrino F, 1998, EUR J CANCER, V34, P2154, DOI 10.1016/S0959-8049(98)00328-1
  11. Bosetti C, 2001, ANN ONCOL, V12, P327, DOI 10.1023/A:1011180524985
  12. Castro MC, 2019, LANCET, V394, P345, DOI 10.1016/S0140-6736(19)31243-7
  13. Chu KP, 2016, CANCER EPIDEMIOL, V40, P102, DOI 10.1016/j.canep.2015.11.010
  14. Conway DI, 2008, INT J CANCER, V122, P2811, DOI 10.1002/ijc.23430
  15. Conway DI, 2015, INT J CANCER, V136, P1125, DOI 10.1002/ijc.29063
  16. Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002
  17. Coviello E, 2015, STATA J, V15, P173, DOI 10.1177/1536867X1501500111
  18. Dantas TS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002314
  19. De Cicco R, 2020, HEAD NECK-J SCI SPEC, V42, P93, DOI 10.1002/hed.25985
  20. Ferreira MAF, 2012, CAD SAUDE PUBLICA, V28, P1663, DOI 10.1590/S0102-311X2012000900006
  21. Fritz A., 2000, INT CLASSIFICATION D
  22. Funda??ao Sistema Estadual de An?lise de Dados-Seade, 2020, IMP INF MUN PAUL
  23. Gatta G, 2015, EUR J CANCER, V51, P2130, DOI 10.1016/j.ejca.2015.07.043
  24. Governo do Estado de Sao Paulo, DECRETO N 51 433 28
  25. Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9
  26. Instituto Brasileiro de Geografia e Estat??stica, TAB COMPL MORT
  27. Kowalski L. P., 1994, European Journal of Cancer, V30B, P167, DOI 10.1016/0964-1955(94)90086-8
  28. Kwok J, 2010, CANCER-AM CANCER SOC, V116, P476, DOI 10.1002/cncr.24774
  29. Llewellyn CD, 2004, ORAL SURG ORAL MED O, V97, P707, DOI 10.1016/j.tripleo.2004.01.007
  30. McDonald JT, 2014, J OTOLARYNGOL-HEAD N, V43, DOI 10.1186/1916-0216-43-2
  31. López RVM, 2014, CANCER CAUSE CONTROL, V25, P461, DOI 10.1007/s10552-014-0348-8
  32. Menezes FD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232871
  33. Perdomo S, 2016, CANCER EPIDEMIOL, V44, pS43, DOI 10.1016/j.canep.2016.03.012
  34. Perme MP, 2012, BIOMETRICS, V68, P113, DOI 10.1111/j.1541-0420.2011.01640.x
  35. Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249
  36. Shin JY, 2018, INT J ORAL MAX SURG, V47, P1250, DOI 10.1016/j.ijom.2018.03.022
  37. United Nations Development Programme, 2020, ATL HUM DEV BRAZ
  38. United Nations Development Programme, 2019, Human development report 2019. Beyond income, beyond averages, beyond today: inequalities in human development in the 21st century
  39. Vaccarella S., REDUCING SOCIAL INEQ
  40. Wang FM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205731
  41. Wong TH, 2017, CANCER-AM CANCER SOC, V123, P1998, DOI 10.1002/cncr.30557
  42. Zigon G, 2011, ANN ONCOL, V22, P165, DOI 10.1093/annonc/mdq306